Aiding the advancement of Alzheimer’s treatment
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Open claims and closed payer claims data are essential for understanding the status and activities of patients along their healthcare journey, but which data type is most useful and when? Whether the intent is to measure the cost effectiveness of a...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
As therapies become increasingly complex and personalized, it is imperative that physicians...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
As life settles into the new normal after the worst of the COVID-19 pandemic, it is clear that...
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
In the rapidly evolving world of real-world data (RWD) for life sciences and commercial applications, data provenance and data quality serve as unwavering cornerstones for actionable insights. Yet, an unsettling trend has emerged in the form of "Zomb...